Beta-blockers in sepsis

Beta-blockers.

Beta-blockers in liver cirrhosis

Since the original description of the effectiveness of β-blockers in lowering the portal pressure and therefore the risk of variceal bleeding, more than 500 articles in the English literature on the use of non selective β-blockers (NSBB) in cirrhosis have been published. The use of NSBB in pre-primary prophylaxis of variceal bleeding is currently not indicated. In primary prophylaxis, patients ...

Beta-adrenergic blockers.

beta-Adrenergic blocking drugs have been available for several years to treat ischemic heart disease and other cardiovascular and noncardiovascular disorders. There are multiple drugs in this class with various pharmacodynamic and pharmacokinetic properties that may be important in specific clinical situations and in avoiding certain adverse reactions. These drugs have been shown to be efficaci...

Beta-blockers for hypertension

BACKGROUND Beta-blockers refer to a mixed group of drugs with diverse pharmacodynamic and pharmacokinetic properties. They have shown long-term beneficial effects on mortality and cardiovascular disease (CVD) when used in people with heart failure or acute myocardial infarction. Beta-blockers were thought to have similar beneficial effects when used as first-line therapy for hypertension. Howev...

Update on beta blockers.

Beta adrenergic blockers have been one of the most prescribed category of drugs during the past 15 years. Recently, many new beta blockers have been introduced because they have unique pharmacokinetic and pharmacodynamic properties that benefit patients. The purpose of this article is to review the pharmacological properties and clinical uses of beta blockers. The latter part of this review wil...